Kidney, lupus and pregnancy;Rein, lupus et grossesse

Revue de Medecine Interne

Volumn 23, Issue 10, 2002, Pages 813-818

  Le Thi Huong, D ^a   Wechsler, B ^a   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Hydroxychloroquine; Lupus nephritis; Pregnancy; Renal insufficiency; Systemic lupus erythematosus

Indexed keywords

HYDROXYCHLOROQUINE;

CLINICAL PRACTICE; EDITORIAL; FERTILITY; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MORTALITY; PREGNANCY; SYSTEMIC LUPUS ERYTHEMATOSUS;

FEMALE; HUMANS; KIDNEY FAILURE; LUPUS NEPHRITIS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROGNOSIS;

EID: 0036798941     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(02)00696-3     Document Type: Editorial

References (35)

1. Berden JHM. Lupus nephritis. Kidney Int 1997;52:538-58.
2. Austin HA, Muenz LR, Joyce KM, Antonovyh T, Kullick ME, Klippel JH, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 1983;75:382-91.
3. Daugas E, Nochy D, Le Thi Huong D, Duhaut P, Beaufils H, Caudwell V, et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 2002;13:42-52.
4. Le Thi Huong D, Papo T, Beaufils H, Wechsler B, Blétry O, Baumelou A, et al. Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine 1999;78:148-66.
5. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 1995;22:1265-70.
6. Steinberg AD, Steinberg AC. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 1991;4:945-50.
7. Boumpas DT, Austin HA, Vaughan EM, Klippel JH, Steinberg AD, Balow JE. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992;340:741-5.
8. Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, et al. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med 2001;135:296-8.
9. Lewis EJ. The treatment of lupus nephritis: Revisiting Galen. Ann Intern Med 2001;135:296-8.
10. Illei GG, Takada K, Parkin D, Austin HA, Crane M, Yarboro C, et al. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy. Long-term follow-up of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum 2002;46:995-1002.
11. Stone JH, Milward CL, Olson JL, Amend WJ, Criswell LA. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era. Arthritis Rheum 1998;41:678-986.
12. Lochhead KM, Pirsch JD, D'Alessandro AM, Knechtle SJ, Kalayoglu M, Sollinger HW, et al. Risk factors for renal allograft loss in patients with systemic lupus erythematosus. Kidney Int 1996;49:512-7.
13. Vaidya S, Sellers R, Kimball P, Shanahan T, Gitomer J, Gugliuzza K, et al. Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: A multicenter study. Transplantation 2000;69:1348-52.
14. Wechsler B, Le Thi Huong D, Vauthier-Brouzes D, Lefebvre G, Gompel AJC, Piette. Hormone stimulation and replacement therapy in women with rheumatic disease. Can we advise ovulation induction in patients with SLE? Scand J Rheumatol 1998;27(suppl 107):53-9.
15. Julkunen H. Pregnancy and lupus nephritis. Scand J Urol Nephrol 2001;35:319-27.
16. Le Thi Huong D, Amoura Z, Duhaut P, Sbai A, Costedoat N, Wechsler B, et al. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 2002 (sous presse).
17. Branch DW, Hatasaka HH. Antiphospholipid antibodies and infertility: Fact or fallacy. Lupus 1998;7(suppl 2):S90-4.
18. Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoat N, Lefèbvre G, et al. The importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome. A single center retrospective study 21 cases and 114 cycles. Sem Arthritis Rheum 2002 (sous presse).
19. Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, Beaufils H, Lefebvre G, Piette JC. Pregnancy in past or present lupus nephritis. A study of 32 pregnancies from a single centre. Ann Rheum Dis 2001;60:599-604,
20. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991;34:1538-45.
21. Ovasiu E, Hicks J, Cameron JS. The outcome of pregnancy in women with lupus nephritis. Lupus 1991;1:19-25.
22. Julkunen H, Kaaja R, Palosuo T, Grbnhagen-Riska C, Teramo K. Pregnancy in lupus nephropathy. Acta Obstet Gynecol Scand 1993;72:258-63.
23. Hayslett JP, Lynn RI. Effect of pregnancy in patients with lupus nephropathy. Kidney Int 1980;18:207-20.
24. Imbasciati E, Surian M, Bottino S, Cosci P, Colussi G, Ambrososo GC, et al. Lupus nephropathy and pregnancy. Nephron 1984;36:46-51.
25. Jungers P, Dougados M, Pelissier C, Kuttenn F, Tron F, Lesavre P, et al. Lupus nephropathy and pregnancy: Report of 104 cases in 36 patients. Arch Intern Med 1982;142:771-6.
26. Packham DK, Lam SS, Nicholls K, Fairley KF, Kincaid-Smith PS. Lupus nephritis and pregnancy. Q J Med 1992;300:315-24.
27. Le Thi Huong D, Wechsler B, Piette JC, Blétry O, Godeau P. Pregnancy and its outcome in systemic lupus erythematosus. Q J Med 1994;87:721-9.
28. The Canadian Hydroxychloroquine study group. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 1991;324:150-4.
29. Levy RA, Vilela VS, Cataldo MJ, Ramos RC, Duarte JL, Tura BR, et al. Hydroxychloroquine in lupus pregnancy: Double-blind and placebo-controlled study. Lupus 2001;10:401-4.
30. Costedoat-Chalumeau N, Amoura Z, Aymard G, Le Thi Huong D, Wechsler B, Vauthier D, et al. Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum 2002;46:1123-4.
31. Klinger G, Morad Y, Westall CA, Laskin C, Spitzer KA, Koren G, et al. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet 2001;358:813-4.
32. Costedoat N, Amoura Z, Duhaut D, Le Thi Huong D, Wechsler B, Vauthier D. Traitement par hydroxychloroquine chez la femme enceinte: Expérience au cours de 101 grossesses. Rev Med Interne 2002;23(suppl 1):74.
33. Borden MB, Parke AL. Antimalarial drugs in systemic lupus erythematosus: Use in pregnancy. Drug Saf 2001;24:1055-63.
34. Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, Lefebvre G, Piette JC. A study of 75 pregnancies in patients with the antiphospholipid syndrome. J Rheumatol 2001;28:2025-30,
35. Shinohara K, Miyagawa S, Fujita T, Aono T, Kidoguchi KI. Neonatal lupus erythematosus: Results of maternal corticosteroid therapy. Obstet Gynecol 1999;93:952-7.